This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Stemirna Therapeutics Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: The Innovations of Hangwen Li
Introduction
Hangwen Li is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biotechnology, particularly through his innovative work at Stemirna Therapeutics Co., Ltd. His expertise and dedication have led to the development of valuable patents that advance scientific research and applications.
Latest Patents
One of Hangwen Li's notable patents is titled "Modified Nucleoside and Synthetic Methods Thereof." This patent reflects his commitment to enhancing nucleoside synthesis, which is crucial for various therapeutic applications. With 1 patent to his name, he continues to push the boundaries of innovation in his field.
Career Highlights
Throughout his career, Hangwen Li has demonstrated exceptional skill and knowledge in biotechnology. His work at Stemirna Therapeutics Co., Ltd. has positioned him as a key player in the development of novel therapeutic solutions. His contributions have not only advanced the company's mission but have also had a broader impact on the industry.
Collaborations
Hangwen Li collaborates with talented individuals such as Yunsong Cai and Lianxiao Liu. These partnerships foster a creative environment that encourages the exchange of ideas and enhances the potential for groundbreaking discoveries.
Conclusion
In summary, Hangwen Li is an influential inventor whose work in biotechnology is paving the way for future innovations. His dedication to research and collaboration exemplifies the spirit of invention that drives progress in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile